Home › Funds › Jones Hill Capital LP › OLMA
Jones Hill Capital LP position in OLMA
OLEMA PHARMACEUTICALS INC · Health Care
Jones Hill Capital LP reported holding 206,397 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.30% of its reported portfolio and ranking #31 among its reported holdings. Jones Hill Capital LP has disclosed OLMA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's OLMA position evolved
Jones Hill Capital LP first disclosed a stake in OLMA in Q2 2026 at 574,166 shares (US$7.2M). Across 2 filings, Jones Hill Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 206,397 shares valued at US$1.8M — a reduction of -367,769 shares quarter over quarter.. Notable position changes include a 64% trim in Q3 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 574.17K | $7.18M | New |
| Q3 2026 | 206.40K | $1.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OLMA and 13F data
OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OLMA
- Paradigm Biocapital Advisors LP 8.67M sh · $108.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.09M sh · $88.64M · Q2 2026
- BVF INC/IL 5.30M sh · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M sh · $41.96M · Q3 2026
- Logos Global Management LP 3.21M sh · $40.14M · Q2 2026
- Cormorant Asset Management, LP 2.15M sh · $26.90M · Q2 2026
- Lightspeed Management Company, L.L.C. 1.36M sh · $16.95M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M sh · $15.01M · Q2 2026
- Defilade Capital Management, L.P. 924.76K sh · $11.57M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held OLMA?
Jones Hill Capital LP has disclosed OLMA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in OLMA?
As of Q3 2026, Jones Hill Capital LP holds 206.40K shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $1.78M, representing 0.30% of its reported portfolio and ranking #31.
Has Jones Hill Capital LP been buying or selling OLMA?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP reduced its position in OLMA.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.